Mgr. Tomáš Thon

Doktorand

Publikace

Front Immunol. 2025 Jan 29;15:1509691

Genetic background and microbiome drive susceptibility to epicutaneous sensitization and food allergy in adjuvant-free mouse model.

Front Immunol. 2024 Dec 16;15:1475126.

Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response.

Journal of Immunology Research. 2023; 2023(20 June 2023); 1535484

Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD

Frontiers in Cellular and Infection Microbiology. 2023; 13(January 10); 1064537

Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy

Frontiers in Immunology. 2023; 13(09 January 2023); 1038328

Effect of Early Postnatal Supplementation of Newborns by Probiotic Strain E. coli O83:K24:H31 on Allergy Incidence; Dendritic cells and Microbiota

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1509691/full

Genetic background and microbiome drive susceptibility to epicutaneous sensitization and food allergy in adjuvant-free mouse model.

PLoS ONE. 2022; 17(12); e0277576

Association between ustekinumab therapy and changes in specific anti-microbial response; serum biomarkers; and microbiota composition in patients with IBD: A pilot study

Cells. 2021; 10(11); 3188

Fecal microbiome changes and specific anti-bacterial response in patients with ibd during anti-tnf therapy